How much funding has Predictive Biosciences raised?

Predictive Biosciences has raised $56.8M in total funding, most recently a Series A round.

Who are Predictive Biosciences's investors?

Predictive Biosciences's investors include Flybridge Capital, Highland Capital Partners.

When was Predictive Biosciences founded?

Predictive Biosciences was founded in 2006.

Where is Predictive Biosciences headquartered?

Predictive Biosciences is headquartered in Lexington, Massachusetts, United States.

What industry is Predictive Biosciences in?

Predictive Biosciences operates in Biotech, Healthcare.

Predictive Biosciences

Lexington, United States · Founded 2006 · $56.8M raised

Biotech

Healthcare

Headquarters: Lexington, Massachusetts
Founded: 2006
Business Model: B2B

Total Funding: $56.8M
Last Round: $10.0M Series AJun 2010
Rounds: 3

About

Predictive Biosciences was a Lexington, Massachusetts-based molecular diagnostics company focused on developing highly accurate, noninvasive urine-based tests for bladder cancer detection and monitoring. The company developed a suite of molecular diagnostic cancer assays, including next-generation sequencing (NGS)-based tests that analyze FGFR3 mutations for bladder cancer detection. Functioning as a fully integrated developer of novel molecular diagnostic cancer assays, Predictive Biosciences partnered with national laboratory networks including ARUP Laboratories. The company raised approximately $56.75 million across multiple funding rounds but ceased operations in 2013 following a CMS contractor decision to deny coverage for its bladder cancer diagnostics products.

Summary

Predictive Biosciences is a Biotech company based in Lexington, United States, founded in 2006. It has raised $56.8M in total across 3 rounds, most recently a $10.0M Series A round in Jun 2010. Investors include Flybridge Capital and Highland Capital Partners.